New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 13, 2013
05:55 EDTTA, TA, OPTT, OPTT, KIRK, KIRK, GLP, GLP, DYN, DYN, DSX, DSX, CORE, CORE, CBRX, CBRX, CBLI, CBLI, ADES, ADESCompanies reporting Before the Market Open on Thursday, March 14
Notable companies reporting before the opening bell on Thursday include ADA-ES (ADES), Cleveland BioLabs (CBLI), Columbia Laboratories (CBRX), Core-Mark Holding (CORE), Diana Shipping (DSX), Dynegy (DYN), Global Partners (GLP), Kirkland's (KIRK), Ocean Power Technologies (OPTT), and TravelCenters of America (TA).
News For ADES;CBLI;CBRX;CORE;DSX;DYN;GLP;KIRK;OPTT;TA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 30, 2015
09:07 EDTDYNWolfe Research to hold a conference
Subscribe for More Information
08:04 EDTCBRXColumbia Laboratories licenses rights for intra-vaginal ring technology
Columbia Laboratories has licensed exclusive worldwide rights to a novel intra-vaginal ring technology for the delivery of one or more pharmaceuticals at different dosages and release rates in a single segmented ring. This technology was developed by scientists Dr. Robert Langer from the Massachusetts Institute of Technology and Dr. William Crowley from Massachusetts General Hospital and Harvard Medical School. Under separate agreements, Drs. Langer and Crowley have joined the company as strategic advisors to support the deployment of this technology and guide development of future product candidates. The company has identified a number of product concepts that could address large market segments and will be prioritizing development of the first candidates in the coming months. Columbia has agreed to minimum annual expenditures to develop products using the vaginal ring technology, and will make milestone-based payments to MGH/MIT when various stages of product development and commercialization are achieved. The company will also share a portion of any royalties or sublicense revenues received from products utilizing the segmented IVR technology with MGH and MIT.
March 29, 2015
13:46 EDTDYNDuke Energy gets approval to sell certain assets to Dynegy for $2.8B in cash
Subscribe for More Information
13:00 EDTDYNDynegy receives final approval from FERC to acquire certain assets
Subscribe for More Information
March 27, 2015
10:03 EDTKIRKOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:57 EDTKIRKKirkland's upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray upgraded Kirkland's to Overweight with a $27 price target saying spending in Texas looks healthy and is not yet a threat to the company. Piper believes the company's growth story is intact and raised its price target for shares to $27 from $26.
March 25, 2015
12:18 EDTDYNFranklin Resources lowers stake in Dynegy to 12.7% from 13.7%
11:40 EDTCORECore-Mark management to meet with Jefferies
Meetings to be held in Austin/Dallas/Houston on March 30-April 1 hosted by Jefferies.
March 24, 2015
09:22 EDTGLPOn The Fly: Pre-market Movers
Subscribe for More Information
08:28 EDTGLPGlobal Partners 1.96M share Spot Secondary priced at $36.10
Barclays acted as sole book running manager for the offering.
March 23, 2015
19:13 EDTGLPOn The Fly: After Hours Movers
Subscribe for More Information
16:27 EDTGLPGlobal Partners files to sell 1.95M common units for limited partners
Subscribe for More Information
09:20 EDTDSXDiana Shipping announces continuation of time charter agreement for Oceanis
Subscribe for More Information
March 18, 2015
17:20 EDTDYNIntegrated Core Strategies reports 5.1% passive stake in Dynegy
Subscribe for More Information
07:03 EDTCBRXColumbia Laboratories 'actively moving forward' focused on 505b2 products
Columbia is actively moving forward as a women's health specialty pharmaceutical company focused on 505(b)2 products. The Company's next product will enter the clinic during the second quarter, and the company is active in identifying and advancing additional, promising drug candidates.
07:03 EDTCBRXColumbia Laboratories sees FY15 revenue growth in low double digits
Subscribe for More Information
07:02 EDTCBRXColumbia Laboratories reports Q4 EPS (5c), consensus 7c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use